Reporter brief
Clinical Translation of Senolytic Therapy With Fisetin to Improve Vascular Function in Older Adults
What happened
Trial registry update: ACTIVE_NOT_RECRUITING. No results reported in the supplied registry record.
Why it matters
Assessment pending; this report does not establish a change in evidence.
What it does NOT prove
- The abstract presents only trial design and objectives, with no outcome data, so no efficacy claims can be assessed.
- Sample size, treatment duration, dosing, and follow-up period are not specified, limiting ability to interpret the trial's power and scope.
- Without reported results, safety, tolerability, and adherence cannot be evaluated.
Study design and sample
Rct; Human.
Older adults
- Design
- Rct
- Sample
- —
- Journal
- University of Colorado, Boulder
- Published
- Sep 25, 2026
Effect size
Not recorded.
Caveats
- Assessment: Unassessed.
- Only the source material recorded on this evidence page was assessed.
Conflicts and funding
Not recorded.
Previous evidence
See the Senolytics timeline and recorded assessment for prior evidence.
Primary source
Cancel Death charts and briefs may be reproduced editorially with attribution to CancelDeath.com. This brief is generated from the primary recorded source facts and assessment. Its review status is shown below; verify quotations against the paper before publication.